Skip to content

Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery

The Effect of the Exclusive Enteral Nutrition Combined With Azathioprine in Maintaining Remission of Patients With Crohn's Diseases After Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04160325
Enrollment
54
Registered
2019-11-13
Start date
2018-01-01
Completion date
2023-10-31
Last updated
2023-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease

Brief summary

for some patients with Crohn's diseases undergoing surgery,whether exclusive enteral nutrition(EEN) could delay the disease relapse needs exploration.The trial will study whether the efficacy of postoperative EEN could help keeping remission.

Detailed description

For patients with Crohn's disease(CD), whether exclusive enteral nutrition(EEN) following bowel resection and anastomosis could delay the disease recurrence remains unkown. In this study, CD patients after surgery will be divided into two groups: one group is treated with 3 months' EEN and then turn to normal diet after 3 months; the other group is given with normal diet all through. All patients will be adminstrated with oral azathioprine after surgery. Then, the rates of 1 year postoperative endoscopic recurrence will be compared between groups.

Interventions

DIETARY_SUPPLEMENTpostoperative 3-month exclusive enteral nutrition

postoperative 3-month exclusive enteral nutrition after surgery and alter to normal food after 3 months

DRUGazathioprine

azathioprine

OTHERnormal diet

normal diet

Sponsors

Zhu Weiming
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* CD patients who undergoing bowel resection with anastomosis

Exclusion criteria

* patients who had administered with immunomodulators or biological agents patients who were created stoma

Design outcomes

Primary

MeasureTime frameDescription
the 1 year postoperative anastomotic recurrence1 yearthe 1 year postoperative anastomotic recurrence

Countries

China

Contacts

Primary Contactweiming zhu
juwiming@nju.edu.cn+86-025-80860036
Backup Contactming duan
duanming1206@126.com+86-025-80860037

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026